VB10.16

· Nykode Therapeutics ASA

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VB10.16, covering 2022-07-13 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

See pricing